CAS: 2305154-31-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine REF: IN-DA01KK6JCAS: 2305154-31-6 | 97% | 108.00 €~216.00 € | Tue 07 Jan 25 |
 | JCN037 REF: TM-T8431CAS: 2305154-31-6 | 99.50% | 39.00 €~537.00 € | Tue 14 Jan 25 |
 | JCN037 REF: 3D-FSD15431CAS: 2305154-31-6 | Min. 95% | To inquire | Tue 18 Feb 25 |
![N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine](https://static.cymitquimica.com/products/IN/thumb/DA01KK6J.jpg)
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine
CAS:2305154-31-6
Formula:
C16H11BrFN3O2
Purity:
97%
Molecular weight:
376.1798
Ref: IN-DA01KK6J
| 25mg | 108.00 € | ||
| 50mg | 179.00 € | ||
| 100mg | 216.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
JCN037
CAS:2305154-31-6
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of …
Formula:
C16H11BrFN3O2
Purity:
99.50%
Color and Shape:
Solid
Molecular weight:
376.18
Ref: TM-T8431
| 2mg | 39.00 € | ||
| 5mg | 72.00 € | ||
| 10mg | 102.00 € | ||
| 25mg | 172.00 € | ||
| 50mg | 263.00 € | ||
| 100mg | 377.00 € | ||
| 200mg | 537.00 € | ||
| 1mL*10mM (DMSO) | 81.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
JCN037
CAS:2305154-31-6
JCN037 is a potent, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in clinical …
Formula:
C16H11BrFN3O2
Purity:
Min. 95%
Molecular weight:
376.18 g/mol
Ref: 3D-FSD15431
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
